Sort
21,281 grants matching “influenza”
Chimeric VLP Vaccines for Viral Hemorrhagic Fever
$228,000Emory University · R21 · FY2002 · AI
Receptor tyrosine kinase signaling and influenza viral RNA synthesis
$228,000Yuying Liang · University Of Minnesota · R21 · FY2013 · AI
Role of OCIAD1 in RIG-I-mediated STAT1 signaling pathway
$228,000Shitao Li · Tulane University Of Louisiana · R21 · FY2022 · AI
Effectiveness and Safety of Tdap Immunization in Pregnancy
$228,000Sylvia Irene Becker-Dreps · Univ Of North Carolina Chapel Hill · R21 · FY2015 · AI
Development of broadly-protective vaccines for influenza B viruses
$227,774Yoshihiro Kawaoka · University Of Wisconsin-Madison · R21 · FY2021 · AI
RESPIRATORY INFECTIONS, IMMUNITY, AND HEMOSTASIS IN AGING
$227,673University Of Rochester · P60 · FY2000 · AG
Modeling Epidemic Infectious Diseases Using Sequence Analysis
$227,623Sergei L Kosakovsky Pond · University Of California, San Diego · U01 · FY2015 · GM
MSCs therapy for acute lung injury and its effect on antiviral immunity
$227,535Mahesh Khatri · Ohio State University · R21 · FY2015 · HL
Severe H1N1 Influenza Infection During Pregnancy: Pathophysiologic Mechanisms
$227,500Mark Phillippe · University Of Vermont & St Agric College · R21 · FY2010 · HD
Molecular target of a novel broad-spectrum antiviral and antibacterial compound
$227,480Daniel D Rockey · Oregon State University · R21 · FY2016 · AI
Cell-specific restriction of influenza A virus assembly
$227,440Akira Ono · University Of Michigan At Ann Arbor · R21 · FY2020 · AI
Integrating health and biology in a science curriculum for Latino preschoolers
$227,426Laura F Romo · University Of California Santa Barbara · R25 · FY2014 · OD
Microarray Analysis of Translational Regulatory Pathways
$227,400University Of Washington · R21 · FY2003 · AI
Microarray Analysis of Translational Regulatory Pathways
$227,400University Of Washington · R21 · FY2002 · AI
Pilot Core
$227,307David I Laibson · National Bureau Of Economic Research · P30 · FY2013 · AG
Evaluating macrophage antiviral immunity as a suppressive factor in SIV-M. tuberculosis co-infection
$227,281Joshua T. Mattila · University Of Pittsburgh At Pittsburgh · R21 · FY2022 · AI
Paramyxoviruses as Vaccine Vectors Against Highly Pathogenic Viruses
$227,201Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Mechanisms of Cardioprotection by the Innate Immune System During Influenza Virus Infections
$227,185Murugesan Rajaram · Ohio State University · R21 · FY2019 · AI
Innate and adaptive immune responses at the respiratory mucosa
$227,162Yasmin Thanavala · Roswell Park Cancer Institute Corp · R21 · FY2010 · AI
Haemophilus ducreyi Resistance to Antimicrobial Peptides
$227,125Margaret E Bauer · Indiana Univ-Purdue Univ At Indianapolis · R21 · FY2007 · AI
Tetramer Core
$227,117Thomas C Greenough · Univ Of Massachusetts Med Sch Worcester · P01 · FY2007 · AI
SELF-REGULATION DEPRESSIVE/ANXIOUS SYMPTOMS AND URIs
$227,076University Of Wisconsin Madison · R01 · FY2000 · MH
Physician Scientist Training in Age-Related Diseases
$227,061Lona Mody · University Of Michigan At Ann Arbor · T32 · FY2024 · AG
Chemokines in Radiation Induced Pulmonary Fibrosis
$227,033Suzanne L Kirby · Univ Of North Carolina Chapel Hill · R01 · FY2007 · CA
Interdisciplinary Training in Virology and Gene Therapy
$227,028Ren Sun · University Of California Los Angeles · T32 · FY2011 · AI